The RBI postponed implementation of revised capital market exposure guidelines by three months, shifting the deadline from April 1 to July 1, 2026. Originally issued in February 2026, the amended rules aim to ease acquisition financing by Indian companies, streamline lending limits against shares, and adopt a principles-based approach for market intermediaries. The deferral follows requests from banks, capital market intermediaries, and industry bodies seeking more time and clarity on operational issues.

Capital market exposure norms govern how much banks can lend against shares, debentures, and similar instruments, and under what conditions they can finance corporate acquisitions. When RBI first issued these revised guidelines in February 2026, the intent was to modernise a regulatory framework that had grown piecemeal over years — making it more principles-based rather than prescriptive rule-by-rule. The practical significance is large: India's M&A activity has been accelerating, and acquisition finance — where a bank lends to help a company buy another — requires clarity on permitted structures. The new rules expand the definition of acquisition finance to include mergers and amalgamations (not just outright purchases), restrict such lending to non-financial company targets, and allow Indian firms to use acquisition finance to fund subsidiaries — domestic or overseas — buying target companies. The synergy condition for holding/parent company targets is a safeguard against banks financing circular structures. The three-month extension is routine in Indian banking regulation, especially when rules involve complex operational integration with custodians, depositories, and margin systems. For RBI Grade B aspirants, this topic sits at the intersection of RBI's regulatory functions, prudential norms, and capital markets — all core ESI and FM paper areas. Expect questions framed around the purpose of the guidelines, the revised deadline, and the specific carve-outs introduced.